Large SGEN Owner Buying Up Stock; StreetInsider Takes Notice
Tweet Send to a Friend
Seattle Genetics, Inc. (Nasdaq: SGEN) 10% owner, Baker Biotech Capital, discloses a number of traunches of buying ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
